Skip to content
Telehealth Graded
State guide

New Jersey's state health plan and GLP-1s

A GLP-1 costs a New Jersey state employee $45 a month, or $125 a month, and the difference is whether you're enrolled in a program the state has to go and hire first. The resolution that did this names the drugs, names the price on both sides, and carves out two plans entirely.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
6
sourced facts
2
primary sources

What changed, and what the document says

  1. The copay that exists today

    Covered

    $45 for thirty days, running since November 1, 2025.

    As of November 1, 2025, the member co-payment for non-diabetic GLP-1 drugs for weight loss shall be $45 per 30-day prescription in the SHBP Plans.

    State of New Jersey, State Health Benefits Program Plan Design CommitteeSeptember 24, 2025

  2. The copay that replaces it

    Not covered

    Once a lifestyle program is running, the price forks. Skip the program and it's $125.

    $125 per 30-day supply if the member is not participating in the lifestyle management program.

    State of New Jersey, State Health Benefits Program Plan Design CommitteeSeptember 24, 2025

  3. The fork itself

    Conditions apply

    Both halves take effect on the same day, and that day is whenever a vendor is under contract.

    Upon implementation of a lifestyle management program designed to support members prescribed non-diabetic GLP-1 drugs for weight loss, the co-payments for SHBP Plan members prescribed such products after that implementation date shall be:

    State of New Jersey, State Health Benefits Program Plan Design CommitteeSeptember 24, 2025

  4. Which drugs the rule covers

    Context

    A footnote does the defining, and it reaches past the three named products.

    indicated for therapeutic use in conditions other than diabetes—primarily for chronic weight management and obesity-related comorbidities—and include, but are not limited to, Zepbound, Wegovy, and Saxenda.

    State of New Jersey, State Health Benefits Program Plan Design CommitteeSeptember 24, 2025

  5. Retirees are outside it

    Context

    The resolution stops at active employees. Early and Medicare-eligible retirees are not in this at all.

    This Resolution shall apply to active employees and shall not apply to early or Medicare eligible retirees.

    State of New Jersey, State Health Benefits Program Plan Design CommitteeSeptember 24, 2025

  6. Two plans are carved out

    Conditions apply

    The open-enrollment sheet adds a mail-order figure and an exclusion the resolution never mentions: the high-deductible plans don't get this copay.

    Effective January 1, 2026, GLP-1 weight loss drugs Wegovy, Saxenda, and Zepbound have a $45 copayment for a 30-day retail supply and a $135 copayment for a 90-day mail-order supply. (This does not apply to the HDHigh and HDLow plans.)

    New Jersey Division of Pensions & BenefitsPlan Year 2026

Which of these companies serve New Jersey?

Of the 101 companies we grade, 12 publish a list of the states they are licensed in. We checked 86 more and found no such list on any page we read; 3 we have not checked either way.

6 of those lists name New Jersey: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity and WePeptideRx. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.